Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M

[ad_1]

Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42.

[ad_2]

Source link